Title: Adalimumab induction therapy for Crohn disease previously treated with infliximab - A randomized trial
Authors: Sandborn, William J ×
Rutgeerts, Paul
Enns, Robert
Hanauer, Stephen B
Colombel, Jean-Frederic
Panaccione, Remo
D'Haens, Geert
Liu, Junhu
Rosenfeld, Marie R
Kent, Jeffrey D
Pollack, Paul F #
Issue Date: Jun-2007
Publisher: American College of Physicians
Series Title: Annals of Internal Medicine vol:146 issue:12 pages:829-838
Abstract: Background: Adalimumab, a fully human tumor necrosis factor (TNF) antagonist, is an effective treatment for patients with Crohn disease who are naive to the chimeric TNF antagonist, infliximab. No anti-TNF agent has been evaluated prospectively in patients with Crohn disease who had responded to another anti-TNF agent and then lost that response or were intolerant of the agent.
ISSN: 0003-4819
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Translational Research in GastroIntestinal Disorders
Medicine Teaching Programs
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science